Eaton Vance Management’s Guardant Health GH Stock Holding History

Eaton Vance Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$9.17M	Buy	170,416 +925	+0.5%	+$47.5K	0.01%	623
2022 Q2	$6.84M	Buy	169,491 +506	+0.3%	+$25.1K	0.01%	723
2022 Q1	$11.2M	Buy	168,985 +20,793	+14%	+$1.42M	0.01%	663
2021 Q4	$14.8M	Sell	148,192 -244	-0.2%	-$25.2K	0.02%	538
2021 Q3	$18.5M	Buy	148,436 +305	+0.2%	+$36.2K	0.03%	447
2021 Q2	$18.4M	Sell	148,131 -346	-0.2%	-$46.5K	0.02%	470
2021 Q1	$22.7M	Buy	148,477 +63,609	+75%	+$9.61M	0.03%	414
2020 Q4	$10.9M	Buy	84,868 +1,097	+1%	+$126K	0.02%	521
2020 Q3	$9.36M	Hold	83,771	–	–	0.02%	494
2020 Q2	$6.8M	Buy	83,771 +3,216	+4%	+$259K	0.01%	534
2020 Q1	$5.61M	Buy	+80,555	New	+$6.18M	0.01%	523

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Eaton Vance Management's GH Position: Q3 2022 in Review

Eaton Vance Management increased its Guardant Health (GH) stake by 0.55% in Q3 2022, buying an estimated $47.5K and bringing the position to 170,416 shares worth $9.17M. The position accounts for 0.01% of the portfolio, ranked #623.

Eaton Vance Management first reported a position in GH in Q1 2020 and has held it in 11 quarters since. The position peaked at $22.7M in Q1 2021. 328 funds tracked by Wall St. Rank hold GH as of Q3 2022.

Eaton Vance Management held 170,416 shares of Guardant Health worth $9.17M as of Q3 2022.
Eaton Vance Management bought 925 Guardant Health shares in Q3 2022, an estimated $47.5K.
Guardant Health made up 0.01% of Eaton Vance Management's portfolio in Q3 2022, its #623 holding.
Eaton Vance Management first reported a position in Guardant Health in Q1 2020 and has held it in 11 quarters since.
Eaton Vance Management's Guardant Health position peaked at $22.7M in Q1 2021.
328 funds tracked by Wall St. Rank held Guardant Health as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.